World's Best Scientists 2026 revealed!
Daniela Galimberti

Daniela Galimberti

D-Index & Metrics

Medicine

D-Index
99
Citations
43963
World Ranking
8480
National Ranking
285

Overview

Daniela Galimberti is affiliated with the University of Milan in Italy, with a research focus primarily within the field of Medicine. Their work spans multiple subfields, including Neurology, Physiology, Psychiatry and Mental Health, Molecular Biology, and Genetics.

Their research predominantly addresses topics such as Alzheimer's disease research and treatments, Amyotrophic Lateral Sclerosis research, Dementia and cognitive impairment studies, Prion diseases and protein misfolding, Parkinson's disease mechanisms and treatments, Functional brain connectivity, and Multiple sclerosis research.

Some recent publications associated with Daniela Galimberti include:

  • A multicentre validation study of the diagnostic value of plasma neurofilament light, 2021, Nature Communications
  • Common variants in Alzheimer's disease and risk stratification by polygenic risk scores, 2021, Nature Communications
  • Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders, 2020, Brain
  • Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease, 2022, Nature Genetics
  • Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia, 2020, Journal of Neurology Neurosurgery & Psychiatry

Frequent co-authors in Galimberti's work include Barbara Borroni, Caroline Graff, Simon Ducharme, Raquel Sánchez-Valle, and Alexandre de Mendonça.

Galimberti has published extensively in journals such as Alzheimer's & Dementia, bioRxiv (Cold Spring Harbor Laboratory), Journal of Alzheimer's Disease, Journal of Neurology Neurosurgery & Psychiatry, and Neurology.

Best Publications

  • Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

    Jean-Charles Lambert;Jean-Charles Lambert;Jean-Charles Lambert;Carla A Ibrahim-Verbaas;Denise Harold;Adam C Naj

  • Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

    Stephen Sawcer;Garrett Hellenthal;Matti Pirinen;Chris C. A. Spencer

  • Genome-wide association study indentifies variants at CLU and CR1 associated with Alzheimer’s disease

    J Lambert;S Heath;G Even;D Campion

  • Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.

    Paul Hollingworth;Denise Harold;Rebecca Sims;Amy Gerrish

  • Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.

    Valentina Escott-Price;Céline Bellenguez;Li-San Wang;Seung-Hoan Choi

  • Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

    Ashley H. Beecham;Nikolaos A. Patsopoulos;Nikolaos A. Patsopoulos;Dionysia K. Xifara;Mary F. Davis

  • Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

    Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez

  • APOE and Alzheimer disease: a major gene with semi-dominant inheritance

    E Genin;D Hannequin;D Wallon;K Sleegers

  • Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis

    Jonathan D Rohrer;Jennifer M Nicholas;Jennifer M Nicholas;David M Cash;John van Swieten

  • Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference

    Alexandra L Young;Razvan V Marinescu;Neil P Oxtoby;Martina Bocchetta

  • A multicentre validation study of the diagnostic value of plasma neurofilament light.

    Nicholas J. Ashton;Shorena Janelidze;Ahmad Al Khleifat;Antoine Leuzy

  • The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

    Niklas Mattsson;Ulf Andreasson;Staffan Persson;Hiroyuki Arai

  • Frontotemporal dementia and its subtypes: a genome-wide association study

    Raffaele Ferrari;Raffaele Ferrari;Dena G Hernandez;Dena G Hernandez;Michael A Nalls;Jonathan D Rohrer

  • CSF biomarker variability in the Alzheimer's Association quality control program

    Niklas Mattsson;Niklas Mattsson;Ulf Andreasson;Staffan Persson;Maria C. Carrillo

  • A Polymorphism in CALHM1 Influences Ca2+ Homeostasis, Aβ Levels, and Alzheimer's Disease Risk

    Ute Dreses-Werringloer;Jean Charles Lambert;Valérie Vingtdeux;Haitian Zhao

  • Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.

    Daniela Galimberti;Niki Schoonenboom;Philip Scheltens;Chiara Fenoglio

  • Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status.

    Laura Piccio;Yuetiva Deming;Jorge L. Del-Águila;Laura Ghezzi;Laura Ghezzi

  • Consensus guidelines for lumbar puncture in patients with neurological diseases

    Sebastiaan Engelborghs;Ellis Niemantsverdriet;Hanne Struyfs;Kaj Blennow

  • Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

    J. Kuhle;G. Disanto;R. Dobson;R. Adiutori

  • Plasma ghrelin concentrations in elderly subjects: Comparison with anorexic and obese patients

    AE Rigamonti;AI Pincelli;B Corra;R Viarengo

Frequent Co-Authors

Elio Scarpini
Elio Scarpini University of Milan
Nereo Bresolin
Nereo Bresolin University of Milan
Caroline Graff
Caroline Graff Karolinska University Hospital
Sandro Sorbi
Sandro Sorbi University of Florence
Barbara Borroni
Barbara Borroni University of Brescia
Fabrizio Tagliavini
Fabrizio Tagliavini Istituto Neurologico Carlo Besta
Mario Masellis
Mario Masellis Sunnybrook Health Science Centre
Jonathan D. Rohrer
Jonathan D. Rohrer University College London
John C. van Swieten
John C. van Swieten Erasmus University Rotterdam
James B. Rowe
James B. Rowe University of Cambridge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative or complementary healthcare degrees can open doors to rewarding careers beyond a traditional MD. Many students consider healthcare administration, nursing practice, or pharmacy, all of which now offer flexible online degree options.

For those interested in leadership and management within healthcare organizations, pursuing an online master of health administration is a popular choice. These programs equip you with the skills to oversee hospitals, clinics, and other medical facilities. If affordability is a priority, there are cheapest mha programs online that offer quality education without a hefty price tag.

Advanced nursing careers, such as nurse practitioners or administrators, often require a Doctor of Nursing Practice (DNP). The best online dnp programs combine clinical expertise with leadership training, and many are tailored for working professionals.

Interested in medications and patient health? Pharmacy school online programs provide a pathway to becoming a pharmacist, mixing pharmaceutical sciences with patient care—all accessible from anywhere.

Best Scientists Citing Daniela Galimberti

Trending Scientists

Recently Published Articles